Torrent Pharmaceuticals Ltd. logo

Torrent Pharmaceuticals Ltd. (TORNTPHARM)

Market Closed
10 Aug, 10:00
XNSE XNSE
4,924. 00
0
0%
1.45T Market Cap
59.74 P/E Ratio
58% Div Yield
416,371 Volume
0 Eps
4,924
Previous Close
Add Transaction
Day Range
4,885 4,981.5
Year Range
3,480.6 5,250
Want to track TORNTPHARM and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

TORNTPHARM closed today higher at ₹4,924, an increase of 0% from yesterday's close, completing a monthly increase of 5.9631% or ₹277.1. Over the past 12 months, TORNTPHARM stock gained 27.5648%.
TORNTPHARM pays dividends to its shareholders, with the most recent payment made on Jun 25, 2026. The next estimated payment will be in In 4 months on Dec 25, 2026 for a total of ₹9.
The last earnings report, released on May 21, 2026, missed the consensus estimates by -20.22%. On average, the company has fell short of earnings expectations by -12.87%, based on the last three reports.
Torrent Pharmaceuticals Ltd. has completed 3 stock splits, with the recent split occurring on Jul 08, 2022.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on XNSE (INR).

TORNTPHARM Chart

People also search for

Sun Pharmaceutical Industries Ltd.
1,944.4
-0.0308%
Tata Motors Ltd.
347.1
+0.0288%
Maruti Suzuki India Limited
14,097
+0.4274%
M&M
Mahindra & Mahindra Ltd.
3,517
+0.4283%
Bajaj Auto Limited
11,677
+0.1286%

Torrent Pharmaceuticals Ltd. (TORNTPHARM) FAQ

What is the stock price today?

The current price is ₹4,924.00.

On which exchange is it traded?

Torrent Pharmaceuticals Ltd. is listed on XNSE.

What is its stock symbol?

The ticker symbol is TORNTPHARM.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 58%.

What is its market cap?

As of today, the market cap is 1.45T.

Has Torrent Pharmaceuticals Ltd. ever had a stock split?

Torrent Pharmaceuticals Ltd. had 3 splits and the recent split was on Jul 08, 2022.

Torrent Pharmaceuticals Ltd. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Mr. Sanjay Gupta CEO
XNSE Exchange
Y8896L148 CUSIP
India Country
17,059 Employees
29 May 2026 Last Dividend
8 Jul 2022 Last Split
- IPO Date

Overview

Torrent Pharmaceuticals Limited is a prominent player in the pharmaceutical industry, focusing on the research, development, manufacturing, and marketing of generic pharmaceutical formulations. With operations spanning across key markets such as India, the United States, Brazil, Germany, and other international territories, the company has established a significant global presence. Torrent Pharmaceuticals is renowned for its comprehensive product portfolio that caters to various therapeutic areas. Originally founded in 1959 and initially known as Trinity Laboratories, the company underwent a name change to Torrent Pharmaceuticals Limited in 1971. Based in Ahmedabad, India, it functions as a subsidiary of Torrent Investments Private Limited, marking its stature as a noteworthy entity in the pharmaceutical sector.

Products and Services

Torrent Pharmaceuticals Limited offers an extensive range of products and services across various therapeutic areas and specialties:

  • Cardiovascular - The company provides a suite of medications aimed at treating conditions related to the heart and blood vessels.
  • Central Nervous System (CNS) - This includes drugs for the treatment of neurological and psychiatric conditions, highlighting Torrent’s commitment to addressing complex health challenges.
  • Gastro-Intestinal - Solutions for disorders of the gastrointestinal tract, ensuring effective treatment options for digestive health.
  • Women Healthcare - Torrent Pharmaceuticals shows its dedication to women's health through a variety of products catering to the unique healthcare needs of women.
  • Diabetology - Acknowledging the global rise in diabetes, the company offers products designed to help manage and control this condition.
  • Pain Management - Addressing the critical area of pain relief through medications that provide comfort to patients suffering from various types of acute and chronic pain.
  • Gynecology - Providing treatments and therapy options for the health issues specific to the female reproductive system.
  • Oncology - Offering hope with a range of oncology drugs aimed at treating cancer, demonstrating Torrent’s investment in critical care areas.
  • Anti-Infective - These products are essential in fighting infections, encompassing a broad array of antibiotics and anti-infective drugs.
  • Vitamins, Minerals, and Nutrients - Supporting overall health and well-being through supplements that cater to various dietary needs and deficiencies.

In addition to its extensive product line, Torrent Pharmaceuticals Limited extends its capabilities to provide contract manufacturing services, leveraging its expansive infrastructure and manufacturing excellence to collaborate with other firms in the pharmaceutical industry.

Contact Information

Address: Torrent House
Phone: 91 79 2659 9000